Drug General Information
Drug ID	D0XB1M
Former ID	DIB008556
Drug Name	MSH-372
Synonyms	MIV-150; MIV-150)
Drug Type	Small molecular drug
Indication	Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26]		Phase 1	[524596]
Company	Medivir AB
Structure		Download 2D MOL 3D MOL
Formula	C19H17FN4O3
Canonical SMILES	[C@@H]1([C@H](C1)NC(=O)Nc1ccc(cn1)C#N)c1c(c(ccc1F)C(=O)<br />CC)O
PubChem Compound ID	468179
Target and Pathway
Target(s)	HIV reverse transcriptase	Target Info	Inhibitor	[550939]
References
Ref 524596	ClinicalTrials.gov (NCT02033109) Safety, Pharmacokinetics and Acceptability of PC-1005 for Vaginal Use. U.S. National Institutes of Health.
Ref 550939	WO patent application no. 2004,0290,42, Pyrazole derivatives as reverse transcriptase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.